Safdar A*, Rodriguez GH, Rueda-Jaimes AM, Wierda WG, Ferrajoli A, O’Brien S, Koller CA, Musher DM, Bodey GP, Keating MJ. Immunogenicity and safety of multi-dose granulocyte macrophage-colony stimulating factor immune enhancement in patients with chronic lymphocytic leukemia receiving 23-valent polysaccharide pneumococcal vaccine: a prospective, randomized, controlled trial. Abstract # M-1006. The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. September 17–20, 2007, Chicago. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Rodriguez GH, Shpall EJ, Walsh TJ, Kontoyiannis DP, Champlin RE, Kantarjian HM, Rolston KV, RaadII. High-dose caspofungin in cancer patients with invasive fungal infections. Abstract # M-1169. The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. September 17–20, 2007, Chicago. February 2, 2018/in Research Presentations/by Amar Safdar
Safdar A*, Ma J, Walsh TJ, Wingard JR, Chandrasekar PH, Kontoyiannis DP, Champlin RE, Raad II. Nephrotoxicity associated with amphotericin B lipid complex versus liposomal amphotericin B. Abstract # 1168. The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. September 17–20, 2007, Chicago. February 2, 2018/in Research Presentations/by Amar Safdar
Lamaris GA, Lewis RE, Safdar A, Walsh TJ, Kontoyiannis DP. Caspofungin mediated beta-glucan unmasking and enhancement of neutrophil activity against non-Aspergillus moulds. The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. September 17–20, 2007, Chicago. February 2, 2018/in Research Presentations/by Amar Safdar
Georgescu G, Rodriguez GH, Champlin R, & Safdar A. Predictor of response in recipients of hematopoietic stem cell transplantation with serious infections receiving granulocyte macrophage-colony stimulating factor. Abstract # 1061. The 45th Annual Meeting of Infectious Diseases Society of America. San Diego, California, October 4–7, 2007. February 2, 2018/in Research Presentations/by Amar Safdar
Rodriguez GH, Rolston KV, Chemaly RF, Raad II, & Safdar A. Polymicrobial bloodstream infection in cancer patients. Abstract # 1059. The 45th Annual Meeting of Infectious Diseases Society of America. San Diego, California, October 4–7, 2007. February 2, 2018/in Research Presentations/by Amar Safdar
Ghide SG, Jiang Y, Safdar A, Mulanovich VE, Han XY, Raad II, Jacobson KL. Mycobacterium avium complex pulmonary disease in cancer patients: hematologic versus solid tumor. Abstract # 363. The 45th Annual Meeting of Infectious Diseases Society of America. San Diego, California, October 4–7, 2007. February 2, 2018/in Research Presentations/by Amar Safdar
Chemaly RF, Sharma P, Hanmod S, Mattiuzzi G, Cabanillas M, Kantarjian H, Safdar A, Raad I. Cytomegalovirus infection in patients with acute leukemia. Abstract # 757. The 45th Annual Meeting of Infectious Diseases Society of America. San Diego, California, October 4–7, 2007. February 2, 2018/in Research Presentations/by Amar Safdar
Chemaly RF, Hanmod S, Baradhi A, Kontoyiannis D, Adachi J, Mulanovich V, Hachem RY, Safdar A, Raad I. Cytomegalovirus infection in patients with solid tumors. Abstract # 761. The 45th Annual Meeting of Infectious Diseases Society of America. San Diego, California, October 4–7, 2007. February 2, 2018/in Research Presentations/by Amar Safdar
Ramos ER, Hachem R, Mulanovich V, Adachi J, Kontoyiannis D, Rolston K, Safdar A, Raad I, Chemaly RF. MRSA pneumonia in cancer patients: failure rate with vancomycin. Abstract # 247. The 45th Annual Meeting of Infectious Diseases Society of America. San Diego, California, October 4–7, 2007. February 2, 2018/in Research Presentations/by Amar Safdar
